Impact of Smoking and Chronic Obstructive Pulmonary Disease on All-Cause, Respiratory, and Cardio-Cerebrovascular Mortality
DOI: https://doi.org/10.2147/copd.s458356
2024-06-07
International Journal of COPD
Abstract:Hye-Rin Kang, 1, &ast So Jeong Kim, 2, &ast Ju Gang Nam, 3 Young Sik Park, 4 Chang-Hoon Lee 4 1 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Veteran Health Service Medical Center, Seoul, 05368, Republic of Korea; 2 Division of Pulmonology and Allergy, Hallym University Dongtan Sacred Heart Hospital, Gyeonggi-do, 18450, Republic of Korea; 3 Department of Radiology, Seoul National University Hospital, Seoul, 03080, Republic of Korea; 4 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul, 03080, Republic of Korea &astThese authors contributed equally to this work Correspondence: Chang-Hoon Lee, Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-Ro Jongno-Gu, Seoul, 03080, Republic of Korea, Tel +82-2-2072-4743, Fax +82-2-762-9662, Email Introduction: Mortality differences in chronic obstructive pulmonary disease (COPD) between nonsmokers and smokers remain unclear. We compared the risk of death associated with smoking and COPD on mortality. Methods: The study included participants aged ≥ 40 years who visited pulmonary clinics and were categorised into COPD or non-COPD and smoker or nonsmoker on the basis of spirometry results and cigarette consumption. Mortality rates were compared between groups using statistical analysis for all-cause mortality, respiratory disease-related mortality, and cardiocerebrovascular disease-related mortality. Results: Among 5811 participants, smokers with COPD had a higher risk of all-cause (adjusted hazard ratio (aHR), 1.69; 95% confidence interval (CI), 1.23– 2.33) and respiratory disease-related mortality (aHR, 2.14; 95% CI, 1.20– 3.79) than nonsmokers with COPD. Non-smokers with and without COPD had comparable risks of all-cause mortality (aHR, 1.39; 95% CI, 0.98– 1.97) and respiratory disease-related mortality (aHR, 1.77; 95% CI, 0.85– 3.68). However, nonsmokers with COPD had a higher risk of cardiocerebrovascular disease-related mortality than nonsmokers without COPD (aHR, 2.25; 95% CI, 1.15– 4.40). Conclusion: The study found that smokers with COPD had higher risks of all-cause mortality and respiratory disease-related mortality compared to nonsmokers with and without COPD. Meanwhile, nonsmokers with COPD showed comparable risks of all-cause and respiratory mortality but had a higher risk of cardiocerebrovascular disease-related mortality compared to nonsmokers without COPD. Keywords: pulmonary disease, chronic obstructive, smokers, nonsmokers, cigarette smoking, comorbidity Chronic obstructive pulmonary disease (COPD) is the third leading cause of death globally. 1 COPD is persistent airflow limitation and lung tissue damage due to prolonged environmental factor exposure in individuals with a genetic predisposition. 2 Effective inhaled therapy has long been developed for COPD management. 3 Recently, inhaled triple pharmacologic therapy, combining inhaled corticosteroids (ICS), long-acting muscarinic antagonists (LAMA), and long-acting β2-agonists (LABA), has showed treatment effectiveness in severe COPD. 4 The most significant risk factor for the development of COPD is smoking. However, other factors, such as exposure to air pollutants or workplace fumes and dust, genetic factors, and repeated lower airway infections, can also cause COPD, which has been reported in nonsmokers. 5,6 Nonsmokers account for 25–45% of all patients with COPD. Studies have shown that COPD in nonsmokers displays different clinical features than that in smokers. 5,7–12 This distinction is further endorsed in GOLD 2023 which classifies COPD types in nonsmokers as different from COPD in smokers. 3 However, so far, large COPD cohort studies and trials have systematically excluded nonsmokers; therefore, the clinical characteristics and outcomes, including mortality risk in nonsmokers with COPD, have not been fully investigated. 13 A few studies 14–16 have compared mortality risk between smokers with COPD and nonsmokers with COPD. However, these studies have limitations, such as a lack of postbronchodilator spirometry results, 14,15 insufficient adjustment for covariates, 14 and a low number of participants. 16 Studies have reported that nonsmokers with COPD have a milder clinical course and airflow limitation compared with smokers with COPD. 17–19 Therefore, we hypothesized that nonsmokers with COPD show a different mortality risk compared with smokers with COPD. The aim of -Abstract Truncated-
respiratory system